Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
02/21/1996 | EP0518985B1 Improvements in and relating to magnetic resonance imaging |
02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
02/21/1996 | CN1117044A Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same |
02/20/1996 | US5493017 Ring-metalated porphyrins |
02/20/1996 | US5492934 Chemosensory olfactory assay for somatization disorders |
02/20/1996 | US5492924 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
02/20/1996 | US5492687 X-ray contrast agents |
02/15/1996 | WO1996004311A1 Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease |
02/15/1996 | WO1996004259A1 Macrocyclic chelants, their chelates and uses thereof in the diagnostic field |
02/15/1996 | WO1996004249A1 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells |
02/15/1996 | WO1996004020A1 Infectious hiv-2 strains and non-human primates infected therewith |
02/15/1996 | WO1996004018A1 Gas-filled microspheres with fluorine-containing shells |
02/15/1996 | WO1996004017A1 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
02/15/1996 | CA2196599A1 Gas-filled microspheres with fluorine-containing shells |
02/15/1996 | CA2196041A1 Macrocyclic chelants, their chelates and uses thereof in the diagnostic field |
02/14/1996 | EP0696730A1 Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation (PCC) technique |
02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
02/13/1996 | US5491219 Magnetic responsiveness |
02/13/1996 | US5491088 Genetic engineering |
02/13/1996 | US5490991 Directed delivery of radioprotectants using a receptor specific carrier |
02/08/1996 | WO1996003653A1 Superparamagnetic particles, process for their production and their use |
02/08/1996 | WO1996003427A1 Peptide derived radionuclide chelators |
02/08/1996 | WO1996003155A1 Contrast mediums for use in imaging the liver |
02/08/1996 | WO1996003154A1 Use of chelates as x-ray contrast mediums |
02/08/1996 | WO1996003073A1 Process for visualizing tissue metabolism using oxygen-17 |
02/08/1996 | WO1996003070A1 Non-invasive method for diagnosing alzheimer's disease in a patient |
02/08/1996 | DE4428851A1 Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie Iron-containing nanoparticles, their preparation and use in the diagnosis and treatment |
02/08/1996 | CA2194551A1 Peptide derived radionuclide chelators |
02/07/1996 | EP0695195A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads |
02/07/1996 | EP0695194A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates |
02/07/1996 | EP0695138A1 Stabilization of voltage sensitive dyes |
02/06/1996 | USRE35152 Administering detectably labeled immunoglobulin that accumulates at inflammation site |
02/06/1996 | US5489708 Synthesis of ioversol |
02/06/1996 | US5489673 Iodinated borane cage molecules as X-ray contrast media |
02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
02/06/1996 | US5489425 Functionalized polyamine chelants |
02/01/1996 | WO1996002669A1 Conjugates of metal complexes and oligonucleotides, which specifically bond to specific target structures, agents containing these conjugates, their use in nmr diagnosis as well as process for their production |
02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
02/01/1996 | WO1996002235A1 Injectable res avoiding inorganic particles |
02/01/1996 | DE4427821A1 Stabilised super-paramagnetic aggregate particles |
02/01/1996 | DE4426438A1 Verwendung von Chelaten als Röntgenkontrastmittel Use of chelates as X-ray contrast media |
02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
01/31/1996 | EP0694258A2 Mixture of preservatives for diagnostic test fluids |
01/31/1996 | EP0693924A1 METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR |
01/31/1996 | EP0693905A1 Microparticles as ultrasonic contrast media |
01/31/1996 | EP0693904A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
01/30/1996 | US5488133 Iodinated aroyloxy ketones |
01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
01/30/1996 | US5487390 Gas-filled polymeric microbubbles for ultrasound imaging |
01/25/1996 | WO1996001655A1 Cascade-polymer complexes and methods of producing the same |
01/25/1996 | WO1996001654A1 Oral contrast agent for ultrasound diagnostic procedures |
01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
01/25/1996 | CA2194604A1 Oral contrast agent for ultrasound diagnostic procedures |
01/25/1996 | CA2194560A1 Cascade-polymer complexes and methods of producing the same |
01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
01/24/1996 | EP0693288A1 Polymers as contrast media for magnetic resonance |
01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
01/24/1996 | EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
01/24/1996 | EP0692981A1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
01/24/1996 | EP0692977A1 Novel heterocycle based nitrogen-sulfur ligands useful in radiographic imaging agents |
01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
01/23/1996 | US5486275 Decarbonylation an acyl bromide derivative with exposure to ultraviolet light |
01/23/1996 | CA1337969C Stable emulsions of highly fluorinated organic compounds |
01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
01/17/1996 | EP0691854A1 Conjugates of proteins and bifunctional ligands |
01/17/1996 | EP0691813A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
01/17/1996 | EP0577659B1 Cross-linking agent |
01/17/1996 | CN1115180A Hepatobiliary magnetic resonance contrast agents |
01/16/1996 | US5484585 Contain nonionic, cationic, anionic, zwitterionic surfactants, excipients, and water; x-ray contrast and computed tomography; medical diagnosis |
01/16/1996 | US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules |
01/11/1996 | WO1996000902A1 N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels |
01/11/1996 | WO1996000717A1 1-PHENOXY-3-N-ALKYLAMINOPROPAN-2-OL HALOGEN DERIVATIVES USEFUL AS MYOCARDIAL β ADRENERGIC RECEPTOR MARKERS AND AS β-BLOCKING AGENTS |
01/11/1996 | WO1996000588A1 Low viscosity chelating polymers |
01/11/1996 | WO1996000567A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
01/11/1996 | DE4425857A1 Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
01/11/1996 | CA2194150A1 N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels |
01/11/1996 | CA2191878A1 Low viscosity chelating polymers |
01/10/1996 | EP0690991A1 Novel anticoagulant cofactor activity |
01/09/1996 | US5482700 Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast |
01/09/1996 | US5482699 Multinuclear complexes for x-ray imaging |
01/09/1996 | US5482698 Detection and therapy of lesions with biotin/avidin polymer conjugates |
01/09/1996 | US5482039 Process for diagnosing erectile dysfunction, and related methods of treatment |
01/04/1996 | WO1996000211A1 Alpha-(cycloalkyl, aryl and aralkyl)substituted polyiodinated aroyloxy compounds |
01/04/1996 | WO1996000210A1 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging |
01/04/1996 | WO1996000090A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
01/04/1996 | WO1996000089A1 Diatrizoxy ester as x-ray contrast agents for imaging the blood pool and lymphatic system |
01/04/1996 | WO1996000088A1 Hydrophobic polymers capable of forming a micelle for x-ray imaging |
01/04/1996 | WO1996000032A1 Implantable capsule for enhancing cell electric signals |
01/04/1996 | CA2193389A1 Diatrizoxy ester as x-ray contrast agents for imaging the blood pool and lymphatic system |
01/04/1996 | CA2191984A1 Alpha-(cycloalkyl, aryl and aralkyl)substituted polyiodinated aroyloxy compounds |
01/04/1996 | CA2191983A1 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging |
01/04/1996 | CA2170400A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
01/03/1996 | EP0689462A1 Improvements in or relating to contrast agents |
01/03/1996 | EP0689461A1 Improvements in or relating to contrast agents |
01/03/1996 | EP0689450A1 Potassium channel blocking compounds and their use |
01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |